Category: Health
Global respiratory and regenerative products company, AVITA Medical, has made an announcement informing that it has received the first commercial sales order for its the RECELL® Autologous Cell Harvesting Device, or RECELL® System, from U.S. burn centers. The company has also started shipping the product, …
The U.S government has recently proposed a new rule forcing drug makers to disclose prices for prescription medicines in their TV commercials. Sources suggest that the new proposal would include brand-name drugs, covered by the Medicare and Medicaid program, to disclose prices if a typical …
Novartis AG – a renowned Swiss multinational pharmaceutical company has reportedly announced that the SUSTAIN study’s post-hoc analysis on the company’s monoclonal antibody – Crizanlizumab has shown positive results. Reports cite, the analysis reviewed results from a clinical study of over 132 patients over a …
Leading pharmaceutical conglomerate, Akcea Therapeutics and parent Ionis Pharmaceuticals Inc. have recently received approval for their hereditary transthyretin amyloidosis (hATTR) treatment drug, Tegsedi™ by the U.S. Food and Drug Administration (FDA). hATTR being a rare disease causes buildup of amyloid in the peripheral nervous system and …
Swiss pharmaceutical conglomerate, Novartis International AG, has recently announced the acceptance of its secondary progressive multiple sclerosis (SPMS) treatment drug, Siponimod, by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The effects of multiple sclerosis (MS) can significantly impact lives, …
American pharmaceutical conglomerate, Merck & Co. has recently inaugurated a state-of-the-art M Lab™ Collaboration Center in São Paulo, Brazil, so as to serve customers in the Latin America region. Sources suggests that the center will effectively provide life science customers with a shared, exploratory environment, …
The Massachusetts-based immuno-oncology startup GO Therapeutics has reportedly announced to have inked a contract with Roche to develop antibodies for cancer. As per trusted sources, the startup would receive an upfront and near-term funds worth USD 9 million as part of the deal. Reportedly, GO …
Enesi Pharma, a UK-based pharmaceutical firm focused on manufacturing novel injectable solid-dose vaccines, has reportedly announced to have formed a research and development collaboration with Public Health England (PHE). As per trusted sources, the partnership would focus on developing and evaluating unique solid-dose formulations of …
